Loading clinical trials...
Loading clinical trials...
Phase 3 Study of Hyperbaric Oxygen Therapy for Comatose Patients With Acute Domestic Carbon Monoxide Poisoning
Carbon monoxide poisoning still places a burden on the healthcare system worldwide. While oxygen therapy is the cornerstone treatment, the role and practical modalities of hyperbaric oxygen therapy (HBO) remain controversial. This study aimed at comparing two sessions of HBO at 2 absolute atmosphere and one session of HBO at 2 absolute atmosphere followed by 4 hours of normobaric oxygen therapy in comatose adult victims of acute domestic carbon monoxide poisoning.
Age
15 - No limit years
Sex
ALL
Healthy Volunteers
No
Raymond Poincaré Hospital
Garches, France
Start Date
October 1, 1989
Primary Completion Date
January 1, 2000
Completion Date
February 1, 2000
Last Updated
April 8, 2010
170
ACTUAL participants
Hyperbaric oxygen therapy
OTHER
hyperbaric oxygen therapy
OTHER
Lead Sponsor
University of Versailles
Collaborators
NCT06574048
NCT05647707
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05088005